Alsubait Sara, Aljarbou Fahd
*Sara Alsubait, Department of Restorative Dental Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Fahd Aljarbou, King Saud University, Riyadh, Saudi Arabia.
Oper Dent. 2021 Nov 1;46(6):631-640. doi: 10.2341/20-277-LIT.
To evaluate the success rate of direct pulp capping (DPC) with Biodentine in mature permanent teeth with carious vital pulp exposure compared to that of DPC with mineral trioxide aggregate (MTA) by means of a systematic review and meta-analysis.
The two authors searched independently the literature published through July 31, 2020, in five electronic databases (PubMed, the Cochrane Central Register of Controlled Trials, Web of Science Core Collection, the Wiley Online Library, and the SCOPUS database).
The research protocol was previously registered in the PROSPERO database (CRD42020192511). Clinical studies that met the inclusion criteria were chosen and independently screened by the authors.
A custom-designed spreadsheet was used to extract the data. The quality of each study was evaluated by means of the revised Cochrane risk of bias (ROB) tool or the ROB of nonrandomized studies of interventions tool.
Three randomized controlled trials and one retrospective study met the inclusion criteria. Only one study had a high risk of bias. The included studies reported data on a total of 95 participants with an age range of 8-51 years. No significant difference was observed in the overall treatment outcome when comparing Biodentine with MTA (Risk ratio=1.00, 95% confidence interval [0.93-1.07], p=1.00).
Biodentine had comparable clinical and radiographic success to that of MTA when used as a DPC agent in mature permanent teeth with carious vital pulp exposure. Additional high-quality studies are needed.
通过系统评价和荟萃分析,评估在患有龋源性活髓暴露的成熟恒牙中,使用生物陶瓷(Biodentine)进行直接盖髓术(DPC)与使用三氧化矿物凝聚体(MTA)进行直接盖髓术相比的成功率。
两位作者独立检索了截至2020年7月31日在五个电子数据库(PubMed、Cochrane对照试验中央注册库、科学引文索引核心合集、Wiley在线图书馆和SCOPUS数据库)中发表的文献。
研究方案先前已在PROSPERO数据库(CRD42020192511)中注册。符合纳入标准的临床研究由作者选择并独立筛选。
使用定制设计的电子表格提取数据。每项研究的质量通过修订后的Cochrane偏倚风险(ROB)工具或干预性非随机研究的ROB工具进行评估。
三项随机对照试验和一项回顾性研究符合纳入标准。只有一项研究存在高偏倚风险。纳入研究共报告了95名年龄在8至51岁之间参与者的数据。将生物陶瓷与MTA进行比较时,在总体治疗结果方面未观察到显著差异(风险比=1.00,95%置信区间[0.93 - 1.07],p = 1.00)。
在患有龋源性活髓暴露的成熟恒牙中,当生物陶瓷用作直接盖髓剂时,其临床和影像学成功率与MTA相当。需要更多高质量的研究。